What is NiMBAL?
NiMBAL specializes in providing comprehensive dietary therapy resources tailored for individuals managing Inflammatory Bowel Disease (IBD). Their core offering revolves around the Specific Carbohydrate Diet (SCD), aiming to alleviate symptoms and improve patient well-being. The company's digital health platform, coupled with educational materials and specialized recipes, empowers patients to adopt and maintain dietary changes effectively. NiMBAL's mission is to simplify the integration of evidence-based dietary management into daily life, serving patients, healthcare providers, and health-conscious individuals.
How much funding has NiMBAL raised?
NiMBAL has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for NiMBAL?
The substantial enterprise-level funding and recent major strategic investment indicate NiMBAL is poised for significant scaling. This capital infusion is expected to fuel product development, enhance the digital platform's capabilities, and expand outreach to a broader patient and professional audience. NiMBAL's strategic focus on the SCD for IBD management positions it for leadership in a niche but growing segment of the digital health and personalized nutrition market. Future developments will likely involve further research integration and enhanced patient support services.
See full NiMBAL company page
